Moreover, interrupting this event by clinically relevant agents targeting the Src/Ras/MEK/ERK pathway synergistically induces MM cell apoptosis in vitro and in vivo[28], [30], [31]. The gene discussed is SRC; the disease is Miyoshi myopathy.